Catalyst
Slingshot members are tracking this event:
Tracon (TCON) Doses First Patient in Phase 3 TAPPAS Trial Evaluating TRC105 in Treatment of Angiosarcoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TCON |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 16, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Trial Initiation, First Patient Dosing, Phase 3, Tappas, Trc105, Angiosarcoma
